Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer
- 1 September 1997
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 44 (3) , 213-221
- https://doi.org/10.1016/s0167-8140(97)00123-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Serum testosterone—A significant determinant of metastatic relapse for irradiated localized prostate cancerUrology, 1997
- Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behaviorInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicityInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Prostate-specific antigen and radiation therapy for clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Relationship of tumor DNA-ploidy toserum prostate-specific antigen doubling time after radiotherapy for prostate cancerUrology, 1994
- Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implicationsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesUrology, 1994
- The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancerCancer, 1993
- Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volumeCancer, 1993
- A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapyCancer, 1991